Results 231 to 240 of about 3,705,484 (314)
Some of the next articles are maybe not open access.

Enzymic methylation of foreign sulfhydryl compounds

Biochimica et Biophysica Acta, 1961
Abstract A new transmethylating enzyme system in mammalian tissues, catalyzing methyl transfer from S-adenosylmethionine to sulfhydryl compounds, has been studied. A series of “nonphysiological” sulfhydryl compounds (BAL, mercaptoethanol, O-methyl-mercaptoethanol, mercaptoacetic acid, β-mercaptoproprionic acid, methymercaptan and hydrogen sulfide ...
Jon Bremer, David M. Greenberg
openaire   +2 more sources

Adverse effects profile of sulfhydryl compounds in man

The American Journal of Medicine, 1986
Many of the adverse reactions produced by penicillamine and other compounds with an active sulfhydryl group form a distinctive pattern when viewed as a class. Alterations in taste perception, mucocutaneous lesions, proteinuria due to immune-complex membranous glomerulopathy, and pemphigus are adverse reactions that have been encountered with all of the
I. Jaffe
openaire   +3 more sources

Loss and formation of malodorous volatile sulfhydryl compounds during wine storage

Critical Reviews in Food Science and Nutrition, 2019
Gal Y Kreitman   +2 more
exaly   +2 more sources

Incorporation of sulfhydryl compounds into melanins in vitro

Biochimica et Biophysica Acta (BBA) - General Subjects, 1988
Cysteine is known to be involved in pheomelanin synthesis. Available evidence, however, indicates that glutathione may also play an important role in melanogenesis. This in vitro study clarifies how cysteine and glutathione participate in melanogenesis.
S, Ito, Y, Imai, K, Jimbow, K, Fujita
openaire   +2 more sources

Detoxification of urotoxic oxazaphosphorines by sulfhydryl compounds

Journal of Cancer Research and Clinical Oncology, 1981
Urotoxic side effects, especially hemorrhagic cystitis, have so far been a limiting factor in the therapeutic use of cyclophosphamide (Endoxan), ifosfamide (Holoxan), and trofosfamide (Ixoten). The uroprotective agent mesna (Uromitexan) allows regional detoxification in the kidney and the urinary tract, and thus clinical prevention of the urotoxic side
N, Brock, J, Pohl, J, Stekar
openaire   +2 more sources

Home - About - Disclaimer - Privacy